News | Cath Lab | October 02, 2019| Dave Fornell, Editor

Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders

Sanders cancelled the rest of his presidential campaign events until further notice following hospitalization

Two Stents Implanted in Democratic Presidential Candidate Bernie Sanders, suffers chest pain

October 2, 2019 — Democratic presidential candidate Sen. Bernie Sanders (D-VT) was hospitalized with chest pain on Oct. 1 and went to the cath lab to have two stents implanted in his heart, according to news reports (see breaking ABC news report).

(This article was updated Oct. 4 with information in a statement Sanders sent to supporters)

The 78-year-old senator reported chest pain after a campaign rally in Las Vegas yesterday and went a hospital where he underwent the emergency procedure.

Sanders has cancelled the rest of his presidential campaign events until further notice.

Based on a letter from one of his doctors in 2016, he had no previous cardiovascular history.

"I am feeling good, and am fortunate to have good healthcare and great doctors and nurses helping me recover," Sanders wrote in a letter to supporters Oct. 3. "None of us know when a medical emergency might affect us. And no one should fear going bankrupt if it occurs. But the truth is, millions of Americans are not as lucky as I am right now. Today in America, there are some 87 million Americans who are uninsured or underinsured. That is unacceptable to me."

Sanders is a big supporter of providing healthcare to all Americans as a right, not a privilege under the current insurance system. A big plank in his campaign platform is the so called "Medicare for all" proposal. It would be similar to socialized medicine programs offered in most European countries. 

"It is unacceptable to me that today in America, we end up spending almost twice as much as any other major country on healthcare, while our life expectancy continues to decline and our healthcare outcomes lag behind many other countries," Sander said in his statement. "It is unacceptable to me that we give tax breaks to billionaires and large corporations while people are dying because they can't afford to get to a doctor or buy the medicine they need."

“By clinical guidelines, an artery should be about 70 percent blocked before a stent is placed," said Robert A. Harrington, M.D., FAHA, president of the American Heart Association in a release sent out today about the candidate. "This is a fairly common heart procedure — about 434,000 procedures were done in 2014 in the U.S. Often patients require more than one stent.”

To open an artery narrowed by atherosclerosis plaques, a doctor may perform a percutaneous coronary intervention (PCI) or angioplasty. In this procedure, a balloon-tipped catheter is inserted into an artery and moved to the point of blockage. Then the balloon is inflated. This compresses the plaque and opens the narrowed spot. Stents are then usually placed to help keep the artery from collapsing after the balloon procedure. The stent stays in the artery permanently and holds it open to improve blood flow to the heart muscle and relieves the chest pain.

 

Related Presidential Stent Content

Former President George W. Bush Gets Stent Following Coronary CT

President Clinton Receives Two Stents

Related Content

Gallery | Cath Lab | October 31, 2019
This is a photo essay of the interventional cardiology and structural heart technologies on the expo floor and discus
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Cath Lab | October 28, 2019
Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from imaging vendors.
Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

News | Cath Lab | October 28, 2019
October 28, 2019 — Leaders within University Hospitals and the Harrington Heart and Vascular Institute had a vision t
OmniVision Announces Guinness World Record for Smallest Image Sensor

OmniVision's OVM6948 CameraCubeChip, a fully packaged, wafer-level camera module measuring 0.65mm x 0.65mm x 1.158mm, built on OmniVision's OV6948, winner of the Guinness World Record for “The Smallest Image Sensor Commercially Available.”

News | Cath Lab | October 22, 2019
October 22, 2019 — OmniVision Technologies Inc.
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival
News | Cath Lab | September 25, 2019
Ten-year survival rates are similar for bypass surgery and coronary stenting with drug-eluting stents in randomized...
Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Overlay Init